Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED)
Clinical trial NCT00723632 · COMPLETED
Trial details
- NCT number
- NCT00723632
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2005-09-01
- Primary completion
- 2010-12-01
- Enrollment
- 901
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.